Since we observed that AKR1B1 can be expressed by many different cell types in the TME, we next investigated prognostic relationships of AKR1B1 in CRC subgroups defined by the abundance of immune and stromal cells. The gene discussed is AKR1B1; the disease is colorectal carcinoma.